tirzepatide phase 3 study results Shows Superior Weight Loss Over Semaglutide in Trial Weight reduction with different doses

Studies suggest that GLP-1s may cross the blood-brain barrier, which means they could affect the central nervous system

Proactive discussions about discontinuation are also appropriate when: You have achieved your treatment goals , such as reaching target HbA1c levels or desired weight loss, and wish to explore whether ongoing treatment is necessary

With insufficient clinical evidence to prove Semaglutides safety for nursing mothers, these providers may recommend temporary cessation of breastfeeding with infant formula during treatment

Keeping the skin well-hydrated with regular use of emollients can help maintain the skin barrier and reduce susceptibility to irritation

Both semaglutide and Tirzepatide are administered as subcutaneous injections, typically in the abdomen, thigh, or upper arm